154 related articles for article (PubMed ID: 20716857)
21. Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients.
Nemoda Z; Lyons-Ruth K; Szekely A; Bertha E; Faludi G; Sasvari-Szekely M
Behav Brain Funct; 2010 Jan; 6():4. PubMed ID: 20205808
[TBL] [Abstract][Full Text] [Related]
22. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Shaikh S; Collier D; Arranz M; Ball D; Gill M; Kerwin R
Lancet; 1994 Apr; 343(8904):1045-6. PubMed ID: 7909081
[No Abstract] [Full Text] [Related]
23. Family association study between DRD2 and DRD3 gene polymorphisms and schizophrenia in a Portuguese population.
Ambrósio AM; Kennedy JL; Macciardi F; Macedo A; Valente J; Dourado A; Oliveira CR; Pato C
Psychiatry Res; 2004 Mar; 125(3):185-91. PubMed ID: 15051179
[TBL] [Abstract][Full Text] [Related]
24. Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB).
Blum K; Braverman ER; Wu S; Cull JG; Chen TJ; Gill J; Wood R; Eisenberg A; Sherman M; Davis KR; Matthews D; Fischer L; Schnautz N; Walsh W; Pontius AA; Zedar M; Kaats G; Comings DE
Mol Psychiatry; 1997 May; 2(3):239-46. PubMed ID: 9152988
[TBL] [Abstract][Full Text] [Related]
25. Ser-311-Cys polymorphism of the dopamine D2 receptor gene and schizophrenia--an analysis of schizophrenic patients in Fukuoka.
Harano M
Kurume Med J; 1997; 44(3):201-8. PubMed ID: 9339651
[TBL] [Abstract][Full Text] [Related]
26. Association analysis between two functional dopamine D2 receptor gene polymorphisms and schizophrenia.
Hori H; Ohmori O; Shinkai T; Kojima H; Nakamura J
Am J Med Genet; 2001 Mar; 105(2):176-8. PubMed ID: 11304833
[TBL] [Abstract][Full Text] [Related]
27. DRD2 Ser311/Cys311 polymorphism in schizophrenia.
Nanko S; Hattori M; Dai XY; Fukuda R; Kazamatsuri H
Lancet; 1994 Apr; 343(8904):1044. PubMed ID: 7909078
[No Abstract] [Full Text] [Related]
28. An association study of dopaminergic (DRD2) and serotoninergic (5-HT2) gene polymorphism and schizophrenia in a North Indian population.
Kaur G; Singh Chavan B; Gupta D; Sinhmar V; Prasad R; Tripathi A; Garg PD; Gupta R; Khurana H; Gautam S; Margoob MA; Aneja J
Asian J Psychiatr; 2019 Jan; 39():178-184. PubMed ID: 30389402
[TBL] [Abstract][Full Text] [Related]
29. The role of C957T, TaqI and Ser311Cys polymorphisms of the DRD2 gene in schizophrenia: systematic review and meta-analysis.
González-Castro TB; Hernández-Díaz Y; Juárez-Rojop IE; López-Narváez ML; Tovilla-Zárate CA; Genis-Mendoza A; Alpuin-Reyes M
Behav Brain Funct; 2016 Nov; 12(1):29. PubMed ID: 27829443
[TBL] [Abstract][Full Text] [Related]
30. Biological research on schizophrenia.
Toru M
Psychiatry Clin Neurosci; 1998 Dec; 52 Suppl():S170-2. PubMed ID: 9895138
[TBL] [Abstract][Full Text] [Related]
31. Effects of dopamine D2 receptor Ser311Cys polymorphism and clinical factors on risperidone efficacy for positive and negative symptoms and social function.
Lane HY; Lee CC; Chang YC; Lu CT; Huang CH; Chang WH
Int J Neuropsychopharmacol; 2004 Dec; 7(4):461-70. PubMed ID: 15140279
[TBL] [Abstract][Full Text] [Related]
32. Evidence that the BLOC-1 protein dysbindin modulates dopamine D2 receptor internalization and signaling but not D1 internalization.
Iizuka Y; Sei Y; Weinberger DR; Straub RE
J Neurosci; 2007 Nov; 27(45):12390-5. PubMed ID: 17989303
[TBL] [Abstract][Full Text] [Related]
33. Polymorphisms of dopamine D2-like (D2, D3, and D4) receptors in schizophrenia.
Ohara K; Nakamura Y; Xie DW; Ishigaki T; Deng ZL; Tani K; Zhang HY; Kondo N; Liu JC; Miyasato K; Ohara K
Biol Psychiatry; 1996 Dec; 40(12):1209-17. PubMed ID: 8959285
[TBL] [Abstract][Full Text] [Related]
34. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia.
Lawford BR; Young RM; Swagell CD; Barnes M; Burton SC; Ward WK; Heslop KR; Shadforth S; van Daal A; Morris CP
Schizophr Res; 2005 Feb; 73(1):31-7. PubMed ID: 15567074
[TBL] [Abstract][Full Text] [Related]
35. Association between three functional polymorphisms of the dopamine D2 receptor gene and polydipsia in schizophrenia.
Matsumoto C; Shinkai T; De Luca V; Hwang R; Hori H; Lanktree M; Ohmori O; Kennedy JL; Nakamura J
Int J Neuropsychopharmacol; 2005 Jun; 8(2):245-53. PubMed ID: 15850500
[TBL] [Abstract][Full Text] [Related]
36. A functionally deficient DRD2 variant [Ser311Cys] is not linked to alcoholism and substance abuse.
Goldman D; Urbanek M; Guenther D; Robin R; Long JC
Alcohol; 1998 Jul; 16(1):47-52. PubMed ID: 9650635
[TBL] [Abstract][Full Text] [Related]
37. Association study between antipsychotics- induced restless legs syndrome and polymorphisms of dopamine D1, D2, D3, and D4 receptor genes in schizophrenia.
Kang SG; Lee HJ; Choi JE; Park YM; Park JH; Han C; Kim YK; Kim SH; Lee MS; Joe SH; Jung IK; Kim L
Neuropsychobiology; 2008; 57(1-2):49-54. PubMed ID: 18451638
[TBL] [Abstract][Full Text] [Related]
38. Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.
Shen YC; Chen SF; Chen CH; Lin CC; Chen SJ; Chen YJ; Luu SU
J Psychiatr Res; 2009 Mar; 43(6):600-6. PubMed ID: 18926547
[TBL] [Abstract][Full Text] [Related]
39. No association of the Ser/Cys311 DRD2 molecular variant with schizophrenia using a classical case control study and the haplotype relative risk.
Verga M; Macciardi F; Pedrini S; Cohen S; Smeraldi E
Schizophr Res; 1997 May; 25(2):117-21. PubMed ID: 9187010
[TBL] [Abstract][Full Text] [Related]
40. [Dopamine receptor gene (DRD2) polymorphism in patients with endogenous psychoses with regard to their clinical heterogeneity].
Golimbet VE; Aksenova MG; Abramova LI; Kaleda VG; Orlova VA; Brusentseva LN; Nosikov VV
Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(11):50-3. PubMed ID: 11765615
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
